Clinical Trial Update: Pilot CAR-T Cells Therapy for Children/Young Adults With CD19+ R/R Leukemia/Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 trial in Belarus is evaluating a pilot CD19-targeted CAR-T cell therapy for children and young adults with relapsed/refractory B-cell acute lymphoblas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia
• B-cell Lymphoblastic Lymphoma

Drugs mentioned

• CAR-T cell therapy (CD19+) (Chimeric Antigen Receptor T-cell therapy targeting CD19)

Snippet

Sponsor: Belarusian Research Center for Pediatric Oncology, Hematology and Immunology | Conditions: B-cell Acute Lymphoblastic Leukemia, Lymphoblastic B-Cell Lymphoma | Phase 1 | Status: RECRUITING